Bring Ozempic and Wegovy medications to the platform
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Mar 2026
- Due
- 31 Mar 2026
- Delivered
- 26 Mar 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Hims & Hers has entered into an agreement with Novo Nordisk that will bring Ozempic® (semaglutide) 0.5 mg, 1 mg, and 2 mg injections and Wegovy® (semaglutide) pills and injections to the platform later this”
What we found
Evidence strength A What the grades mean
Hims & Hers made Wegovy pills and injections and Ozempic injections available on its platform on March 26, 2026, before the March 31 deadline, though a 7.2 mg Wegovy dose was still pending.
-
A Hims & Hers Health, Inc. - Form 8-K - FY2026
“Hims & Hers has entered into an agreement with Novo Nordisk that will bring Ozempic® (semaglutide) 0.5 mg, 1 mg, and 2 mg injections and Wegovy® (semaglutide) pills and injections to the platform later this month” ✓ confirmed on the page
-
B Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers
“Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill.” ✓ confirmed on the page
-
B Wegovy® Pill and Wegovy® Pen Now Available with Hims & Hers
“today, Hims & Hers is offering direct access to Wegovy® pills, Wegovy injections and Ozempic® injections^1 at all dosage levels.” ✓ confirmed on the page
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Bring
- Deliverable
- Ozempic and Wegovy medications
- Where
- US
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Hims & Hers Health, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2026-HIMS-003653 · Corrections policy